Literature DB >> 5764550

Characterization of cytotoxic isoantisera produced in R3 mice. I. Demonstration of antibodies against the theta-C3H isoantigen.

M Schlesinger, D Hurvitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5764550     DOI: 10.1097/00007890-196902000-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Antigenic properties of subsets of splenic T lymphocytes responding to lectins.

Authors:  M Schlesinger; E Israel; I Gery
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

2.  Antigenic properties of lymph-node cells responding to allogeneic lymphocytes and to various concentrations of lectins.

Authors:  R Rabinowitz; R Laskov; M Schlesinger
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

3.  Macrophage phagocytic recognition sites. Demonstration of selectivity by hetero- and alloantisera.

Authors:  A J Schroit; R Gallily
Journal:  Immunology       Date:  1977-07       Impact factor: 7.397

4.  Subpopulations of mouse spleen lymphocytes. I. Dissociation between the reactivities to different "non-specific" mitogens.

Authors:  L Mugraby; I Gery; D Sulitzeanu
Journal:  Immunology       Date:  1974-04       Impact factor: 7.397

5.  [Determination of lymphocytotoxicity].

Authors:  K E Städtler; L B Cueni; G A Schoenenberger
Journal:  Experientia       Date:  1973-05-15

6.  Reduction of antibody plaque-forming cells by allogeneic antilymphocyte serum.

Authors:  G W Morgan; V M Esposito; W Jarboe
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

7.  Inhibition of the activity of cytotoxic murine T lymphocytes by antibodies to idiotypic determinants.

Authors:  R Rabinowitz; M Schlesinger
Journal:  Immunology       Date:  1980-01       Impact factor: 7.397

8.  Occurrence of a theta-like antigen in rats.

Authors:  T C Douglas
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.